AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
Title: AstraZeneca Halts Phase 1 Cardio Drug Trial; Lisata and Qilu Scrap Deal Date: January 27, 2026 In a recent development, British pharmaceutical bellwether, AstraZeneca, decided to call off the Phase 1 trial for their oral cardio drug candidate, AZD0233.…